Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors (Q36165809)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

Rong Fan

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Cheng Wang

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yang Wang

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Ping Ren

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Pingping Gan

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hui Ji

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Zian Xia

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Suiyu Hu

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Qiongyao Zeng

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Wei Huang

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yebin Jiang

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Xi Huang

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 May 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

101

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The role of heat shock proteins in antigen cross presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Enhancing antigen cross-presentation and T-cell priming by complexing protein antigen to recombinant large heat-shock protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

HSF1 overexpression enhances oncolytic effect of replicative adenovirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Heat shock proteins: linking danger and pathogen recognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Facets of heat shock protein 70 show immunotherapeutic potential.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Heat shock protein 70 is a potent activator of the human complement system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Roles of heat-shock proteins in antigen presentation and cross-presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

The inducible Hsp70 as a marker of tumor immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

Heat shock protein 70-associated peptides elicit specific cancer immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

2 October 2017

AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-10-101

21 January 2018

NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-10-101

21 January 2018

Anti-tumor immune responses following neoadjuvant immunotherapy with a recombinant adenovirus expressing HSP72 to rodent tumors.

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-10-101

21 January 2018

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

23 September 2018

Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419635

23 September 2018

Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heat shock protein vaccines against cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22613625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-10-101

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36165809&oldid=2198287589"